In Re Medtronic, Inc. Implantable Defibrillator

434 F. Supp. 2d 729, 2006 U.S. Dist. LEXIS 41596, 2006 WL 1580029
CourtDistrict Court, D. Minnesota
DecidedJune 5, 2006
Docket05-MDL-1726 JMR/AJB
StatusPublished
Cited by4 cases

This text of 434 F. Supp. 2d 729 (In Re Medtronic, Inc. Implantable Defibrillator) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Medtronic, Inc. Implantable Defibrillator, 434 F. Supp. 2d 729, 2006 U.S. Dist. LEXIS 41596, 2006 WL 1580029 (mnd 2006).

Opinion

ORDER

ROSENBAUM, Chief Judge.

The Court has raised, sua sponte, the question of the continued participation of Mitchell Breit, a partner in the New York law firm of Milberg Weiss Bershad & Schulman LLP (“Milberg Weiss”), as a member of the Plaintiffs’ Steering Committee (“PSC”) in this matter. This question has arisen out of the recent indictment of Milberg Weiss and two of its partners. The Court initiated this inquiry through a telephone conference on May 23, 2006. Notice of the telephone conference was given to plaintiffs’ lead counsel and to defense counsel.

*730 After advising all participants of the nature of the Court’s inquiry, defense counsel was excused from the conference. A record of the telephone conference was taken by an official court reporter, with the transcript available only to persons designated on the record.

During the conference, the Court solicited, and has now received, written submissions from lead counsel and from Mr. Breit. Lead counsel urged Mr. Breit’s continued membership on the PSC. Mr. Breit, himself, by letter dated May 31, 2006, asked the Court to allow his continued participation.

After considering the question, the Court exercises its discretion, and finds that it is in the best interest of the transferee plaintiffs that Mr. Breit and the Mil-berg Weiss firm be severed from their service on the PSC, and from continued service on behalf of the transferee plaintiffs.

In making this decision, the Court considers that this case is a complex matter, having been lodged before the undersigned by the Multi-District Litigation Panel. A transferee judge in such a case bears a particularly heavy burden to protect the transferee plaintiffs. See In re Wireless Telephone Federal Cost Recovery Fees Litigation, 396 F.3d 922, 932 (8th Cir.2005) (“the district court acts as a fiduciary, serving as a guardian of the rights of the ... class members”); Pigford v. Johanns, 416 F.3d 12, 25 (D.C.Cir.2005) (the court has a duty to protect class members); Stewart v. General Motors, 756 F.2d 1285, 1293 (7th Cir.1985) (same); Manual for Complex Litigation, Fourth § 10.224 (2004). 1 The Court bears this responsibility irrespective of, and in addition to, the duty owed to these clients by their respective attorneys.

An MDL transferee judge participates in the selection and supervision of the PSC. In partial fulfillment of this responsibility, this Court directly inquired concerning the ethics of each attorney who volunteered to serve on the PSC. It asked each attorney seeking appointment to the PSC to submit a letter touching his/her own ethics, and the ethical competence of his/ her firm or professional association.

Mr. Breit responded by submitting two separate application letters, each dated December 23, 2005. In the first, Mr. Breit described his firm, Milberg Weiss Bershad & Schulman LLP. In the second, he advised that he had no pending personal ethics complaints, nor had any been previously made against him.

Neither letter contained any reference whatsoever to any investigation of either the Milberg Weiss Bershad & Schulman LLP firm, or of its named partners, Messrs. Bershad and Schulman. Neither letter was updated during the nearly five months from their submission, until May 18, 2006. On that date, Milberg Weiss Bershad & Schulman LLP and two of its partners, David J. Bershad and Steven G. Schulman, were indicted on multiple federal charges. Mr. Breit was not indicted, and there is not the slightest indication that he was implicated in any of the incidents referred to in the 102-page indictment.

*731 The application letter in support of Mil-berg Weiss, as a partnership, referred to a number of the firm’s successful cases. Prominent among these was a reference to the firm’s achievements in the Lincoln Savings and Loan Litigation and the Oxford Health Plans securities fraud cases. These “triumphs” are problematic, however. According to the Indictment, in Count One, Overt Act Nos. 130-144 and 180-188, these cases involved a number of the conspiratorial acts committed by Milberg Weiss and members of the firm’s partnership. The Court considers it extraordinarily likely that the attorneys’ fees realized from those cases have contributed to the firm’s profits over the years — including years in which Mr. Breit has been affiliated with the firm.

Mr. Breit’s May 30, 2006, letter, submitted in response to this Court’s concerns regarding his continued participation on the PSC, emphasizes Milberg Weiss’s commitment to ethical behavior. The letter refers to the recent involvement of an outside law firm which now monitors Mil-berg Weiss’s distribution of earned attorneys’ fees to referring attorneys. This fact, while perhaps commendable, certainly does not exonerate any prior misdeeds, if any have occurred (a subject on which the Court expresses no opinion whatsoever).

Mr. Breit’s May 30, 2006, letter offers no explanation of why the investigation of the Milberg Weiss Bershad & Schulman LLP law firm, an investigation which has been long-pending, was never disclosed to this Court until the indictment was handed up. This failure to disclose is inexplicable in light of this Court’s explicit and expressed concerns that each lawyer’s and law firm’s ethics were to be considered for anyone or any firm acting as members of the plaintiffs’ lead counsel, liaison counsel, or steering committees.

After considering all of these facts, the Court finds it appropriate to excuse Mr. Breit and Milberg Weiss from further service on the PSC, and from providing any further service to the MDL case’s transferee plaintiffs. 2

As indicated above, the Court bears an independent duty to the transferee parties in a Multi-District Litigation case. Had this case involved funds to be distributed to plaintiffs in an MDL case; and had those funds been deposited in a financial institution; and had that institution’s major officers or the institution, itself, been indicted; neither the Court nor the potential recipients’ counsel would hesitate for a moment in removing those funds to protect the MDL plaintiffs. A Court which failed to take such a step to protect the MDL transferees would be grossly derelict in its duties.

In a case such as this, many transferee plaintiffs do not select them case-managing counsel in the traditional fashion. Certainly, many approached their own lawyers and sought legal advice, but when the matter was designated as a Multi-District Litigation case, supervision of the case was handed to a panel of attorneys who — in many, if not most, cases — were not the plaintiffs’ original attorney-of-choice. The Court’s duty to the transferee plaintiffs is *732 focused here.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Unitedhealth Group Incorporated Pslra Litig.
643 F. Supp. 2d 1094 (D. Minnesota, 2009)
In re UnitedHealth Group Inc. PSLRA Litigation
643 F. Supp. 2d 1094 (D. Minnesota, 2009)
In Re Initial Public Offering Securities Litigation
499 F. Supp. 2d 415 (S.D. New York, 2007)
In re Organogenesis Securities Litigation
241 F.R.D. 397 (D. Massachusetts, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
434 F. Supp. 2d 729, 2006 U.S. Dist. LEXIS 41596, 2006 WL 1580029, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-medtronic-inc-implantable-defibrillator-mnd-2006.